Nanocopoeia, Inc. and Saint Paul College sign an agreement

January 10, 2012 01:39 PM US Eastern Timezone

Nanocopoeia is developing a nanotechnology-enabled portfolio of therapeutic products.

Nanocopoeia, Inc. a drug delivery company developing a nanotechnology-enabled portfolio of therapeutic products and the Saint Paul College announce the signing of an agreement for access to the college’s laboratory space, and SEM analytical testing equipment. The company will use the facility and the equipment to conduct experimental research enabling scale-up for commercial production of promising nanopharmaceuticals being developed by the company. The Saint Paul College facility allows Nanocopoeia access to research and characterization tools that will support development of therapeutic nanomedicines in a cGMP environment. For more information, please visit www.nanocopoeia.com.